The Missile Defense Agency is now paying to put a privately built, mass-producible midcourse interceptor through flight testing, a step that moves a startup-funded weapon closer to a role long held by exquisite, government-designed hardware. California-based Long Wall said MDA awarded it $75 million to complete testing of its Cyclops low-cost interceptor, Breaking Defense reported on Oct. 22, 2026. The company announced the award on Thursday, and it says it will match the government's money with an equal amount of its own.
Cyclops is designed to strike enemy missiles midway through their flight. It is a midcourse interceptor like the currently deployed Ground-Based Interceptor built by Northrop Grumman. Long Wall founder Dan Piedmont framed the deal in broad terms. “I think it’s a first of its kind award in long-range missile defense, and a substantive commitment,” Piedmont told Breaking Defense.
How the $75 Million Cyclops Award Is Structured
The award covers completion of testing. Defense Daily described the money as intended “to help it complete flight testing of its Cyclops low-cost midcourse defense interceptor.” Breaking Defense did not report a contract number, a contract type or a period of performance. Long Wall referred a question about the duration of the contract to MDA, which did not respond by press time to Breaking Defense's query.
The unusual piece is the company's side of the ledger. According to the press release as quoted by Breaking Defense, Long Wall has spent its own capital developing the interceptor over the past two years and will keep doing so under the MDA contract. “Throughout the period of performance, Long Wall will invest an additional $75 million at private expense to continue Cyclops design and development,” the release said.
That arrangement produces a program in which government and company dollars arrive in equal measure, at least as the company describes it. MDA's $75 million buys testing; Long Wall's $75 million keeps design and development moving in parallel. The split suggests MDA is willing to pay for validation of a product whose design work the company financed itself.
What Makes Cyclops Different From the Ground-Based Interceptor?
Long Wall unveiled the liquid-fueled Cyclops in December 2025, touting it as the first exo-atmospheric interceptor designed to be mass produced. Defense Daily reported that the company first started developing Cyclops in 2024 and announced it in late 2025 as a surface-launched and mass-producible exo-atmospheric interceptor.
Several design choices separate it from the existing midcourse fleet:
- Shipping-container packaging. Long Wall's website says the interceptor can fit in a shipping container, which lets it launch from the ground or from a sea-based platform.
- Commercial parts. The company says it relies largely on commercial off-the-shelf components and technology in production.
- Additive manufacturing. Long Wall cites 3D printing as part of the Cyclops production approach.
- Basing flexibility. Defense Daily reported that when it announced the system, Long Wall said it aimed to reduce limitations on where Cyclops can be fired, to give the military flexibility.
Taken together, those choices describe an interceptor meant to be moved, shipped and built in volume, a different design philosophy from the Ground-Based Interceptor that currently fills the midcourse role.
From ABL Space Systems to a Missile Defense Pure-Play
Long Wall did not start as a defense company. It was officially established in February 2025 as a rebranding of the former launch firm ABL Space Systems, with a narrow focus on missile defense, according to Breaking Defense. The liquid-fueled design and the emphasis on commercial manufacturing methods may reflect that launch-industry background, where cost per vehicle and production rate commonly drive design decisions, though neither source draws that link.
The company went from rebranding to a public interceptor concept in under a year, and to a government-funded test program in under two. The company says its self-funded work began before MDA money arrived, and the new contract keeps that private investment in place rather than replacing it.
Why MDA Is Buying Low-Cost Interceptors Now
Long Wall’s pitch centers on low cost. A design built from commercial components, produced with 3D printing and sized to fit a shipping container is meant to make interceptors cheaper to buy in quantity and easier to position, though neither source publishes a per-round price.
Breaking Defense noted that MDA is also exploring low-cost options for destroying enemy missiles after they have reentered the atmosphere and are closer to their targets. The Long Wall award puts a similar low-cost approach into the midcourse layer, the segment of the defense architecture covering long-range threats.
The award does not, on its own, commit MDA to buying Cyclops in production quantities. It funds testing. Whether the interceptor can hit a target in space, and at what cost per round once production starts, remains to be demonstrated in that flight test campaign.
What It Means for Contractors
The Long Wall deal offers a template other missile defense entrants should study. MDA paid to finish testing a product the company had already designed with its own money, and the company committed to match that funding. Firms with private capital and a credible prototype now have a public example of the agency buying test validation rather than funding development from the first dollar.
Practical takeaways for companies tracking this market:
- Self-funding can be a competitive advantage. Long Wall reached a test contract after roughly two years of company-financed development. Companies that can show hardware and private investment may find it easier to win test money than companies seeking full development funding.
- Cost-sharing is part of the pitch. The dollar-for-dollar private investment in this award gives MDA more development per government dollar. Expect that structure to shape how future proposals are evaluated.
- Supply chains shift toward commercial sources. An interceptor built largely from off-the-shelf components and 3D-printed parts opens opportunities for commercial suppliers and additive manufacturing shops that have not traditionally served midcourse programs.
- Incumbents face a cost benchmark. If Cyclops performs in testing, established midcourse programs will be measured against a mass-producible alternative.
- Watch for MDA's own disclosure. Key terms, including the contract duration, have not been released. Contractors should watch for any MDA announcement that clarifies the vehicle and timeline before drawing conclusions about follow-on production.
The next milestone is the flight testing itself. Results from that campaign will show MDA whether a commercially built interceptor that fits in a shipping container can perform the midcourse mission at a lower price.
